ArticleBMC pregnancy and childbirth2026
Isolation, prevalence, and antimicrobial resistance profiles of Ureaplasma spp. and Mycoplasma hominis in cervical secretions from pregnant and postpartum women in Hangzhou, China.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveTo evaluate the prevalence and antimicrobial resistance profiles of Ureaplasma spp. and Mycoplasma hominis in cervical secretions samples from pregnant and postpartum women in Hangzhou, China.
methodsWe performed a retrospective analysis of Ureaplasma spp. and Mycoplasma hominis culture positive rates and antimicrobial susceptibility patterns using 1,177 cervical secretion specimens, including 616 from pregnant women, 150 from postpartum women, and 411 from asymptomatic non-pregnant women attending routine gynecological check-ups. All secretion specimens were collected at Zhejiang Provincial People's Hospital clinical microbiology laboratory between January 2017 and July 2023.
resultsAmong 1,177 participants, the overall genital mycoplasma (Ureaplasma spp. and Mycoplasma hominis) colonization rate was 51.60% (607/1,177), with significantly higher prevalence in pregnant women (57.10%, 352/616) compared to other groups. The highest colonization rate occurred in pregnant adolescents < 20 years (66.70%, 4/6). Ureaplasma spp. was the predominant detected species (51.50%, 317/616 in pregnant women), while M. hominis colonization was rare (≤ 0.80% overall). Co-colonization (Ureaplasma spp. + M. hominis) was detected in 4.90% (30/616) of pregnant women. The highest in vitro resistance rates among all genital mycoplasma-positive isolates (Ureaplasma spp. and Mycoplasma hominis) were observed for gatifloxacin (80.26%, 122/152), ciprofloxacin (69.17%, 184/266), and roxithromycin (37.70%, 92/244).
conclusionUreaplasma spp. was the predominant genital mycoplasma colonizing pregnant and postpartum women in Hangzhou, with the highest rate observed among those under 20 years of age. There was high in vitro resistance to commonly used antibiotics such as ciprofloxacin and roxithromycin among the isolates. These findings provide local epidemiologic and antimicrobial susceptibility data for pregnant and postpartum women and highlight the need for further multi-center studies to confirm regional resistance patterns and clarify their clinical implications, including when genital mycoplasma colonization may warrant intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.